Using virtual reality to help manage pain in sickle cell disease patients
Official title: Pilot Study to Investigate the Use of Virtual Reality Devices as an Adjunct to Usual Care for Patients With Sickle Cell Disease Experiencing Vaso-Occlusive Crises
Run by University of Maryland, Baltimore · NCT06184126 · Data updated 2026-11-12
This study is testing if using virtual reality can help adults with sickle cell disease feel less pain during painful episodes.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | University of Maryland, Baltimore Academic / other |
| Locations | 1 site (Baltimore, Maryland) |
| Status | Recruiting |
| Started | November 1, 2024 |
| Main results expected | September 30, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | December 24, 2025 |
| Trial ID | NCT06184126 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 years old with a history of sickle cell disease presenting to the emergency department due to acute pain from vaso-occlusive crises.
✕Probably not a fit
Patients with complicated crises, those not receiving intravenous opioids, or individuals with certain medical conditions that prevent the use of virtual reality will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of virtual reality as an additional treatment for patients with sickle cell disease who are experiencing vaso-occlusive crises. Conducted at the University of Maryland Medical Center, the trial involves enrolling adult patients who meet specific criteria and assessing their pain levels before, during, and after the use of virtual reality devices. Participants will engage with the virtual reality equipment for up to two hours while their pain intensity is measured at four different timepoints. The goal is to determine if virtual reality can provide significant pain relief in conjunction with standard care.
Why it matters
Potential benefit: If successful, this approach could offer a novel, non-pharmacological method to alleviate pain for patients suffering from sickle cell disease.
How similar studies have gone: While the use of virtual reality in pain management is gaining interest, this specific application for sickle cell disease is relatively novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult (age \> 18 years) emergency department patient * History of sickle cell disease * Presenting to the emergency department due to acute pain related to sickle cell disease thought to be due to vaso-occlusive crisis Exclusion Criteria: * Prior enrollment in this study * Presenting with a chief complaint suggestive of a complicated crisis (such as concern for acute chest syndrome, splenic sequestration, hepatic sequestration, pulmonary embolism) as determined by the clinical care provider * Not being treated with intravenous opioids for the vaso-occlusive crisis * Patients who lack the capacity to provide informed consent * Medical history of seizures or known intolerance to virtual reality * Disabilities like vision and hearing defects etc. that preclude the use of a head mounted virtual reality device. * Known to be pregnant * Incarcerated at the time of evaluation * Over the age of 89 years old
Where it's running
-
University of Maryland Medical Systems
Baltimore, Maryland, United States Recruiting
Study contacts
- Principal investigator: R. Gentry Wilklerson, MD — U of Maryland, Baltimore
- Study coordinator: R. Gentry Wilkerson, MD
- Email: gwilkerson@som.umaryland.edu
- Phone: 410-328-4237
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Low-dose ketamine for sickle cell vaso-occlusive pain in children and young adults
This trial will test whether adding a low (sub-dissociative) dose ketamine infusion to usual IV opioid pain medicine helps children and young adults (ages 5–20) with sickle cell disease have better pain relief and remain safe during a vaso-occlusive episode.
-
Predictors of severe pain within 24 hours after cesarean delivery with spinal anesthesia
This study will look at which pre-, intra-, and post-operative factors are linked to severe pain in the first 24 hours after an elective cesarean done with spinal anesthesia.
-
Cerebrovascular Reactivity Testing with HD-DOT in Sickle Cell Patients
This study tests whether high-density diffuse optical tomography can measure brain blood flow and oxygen use in people with sickle cell disease, to see how these signals relate to stroke risk.
-
Adapting and testing PEN-Plus in Zambian primary care
Aiming to see if the PEN-Plus package can be adapted and used in two Zambian hospitals to better manage chronic diseases like heart disease, diabetes, hypertension, and sickle cell in primary care.
-
Transverse vs Longitudinal Serratus Anterior Plane Block for Breast Surgery
This trial tests whether a longitudinal ultrasound view for serratus anterior plane block provides better pain relief after breast surgery than the standard transverse view.
-
Combined PECS II and PIP blocks vs TPVB for post-mastectomy pain relief
This trial tests whether a combination of PECS II and superficial PIP blocks can provide better or similar pain relief after mastectomy compared with the standard thoracic paravertebral block.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.